litlas
Log inCreate account

E. David Crawford

Active 1980–2025

169
Papers
52,406
Citations
104
h-index
155
i10-index

Citations

Citations per year for E. David Crawford1896: 1 citations1931: 1 citations1953: 1 citations1974: 2 citations1980: 1 citations1981: 1 citations1982: 3 citations1985: 1 citations1987: 2 citations1988: 1 citations1989: 3 citations1990: 6 citations1991: 17 citations1992: 23 citations1993: 36 citations1994: 26 citations1995: 47 citations1996: 41 citations1997: 44 citations1998: 57 citations1999: 67 citations2000: 99 citations2001: 91 citations2002: 133 citations2003: 154 citations2004: 166 citations2005: 233 citations2006: 250 citations2007: 295 citations2008: 359 citations2009: 448 citations2010: 474 citations2011: 469 citations2012: 448 citations2013: 505 citations2014: 445 citations2015: 391 citations2016: 354 citations2017: 272 citations2018: 343 citations2019: 918 citations2020: 869 citations2021: 843 citations2022: 640 citations2023: 517 citations2024: 830 citations2025: 327 citations2026: 16 citations1897–1930: no citations, so these years are not shown1932–1952: no citations, so these years are not shown1954–1973: no citations, so these years are not shown1975–1979: no citations, so these years are not shown1983–1984: no citations, so these years are not shown1986: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,102 citing papers, 29.8% of this breakdownUnited Kingdom: 1,230 citing papers, 7.2% of this breakdownCanada: 929 citing papers, 5.4% of this breakdownGermany: 882 citing papers, 5.2% of this breakdownChina: 873 citing papers, 5.1% of this breakdownItaly: 860 citing papers, 5% of this breakdownFrance: 688 citing papers, 4% of this breakdownNetherlands: 618 citing papers, 3.6% of this breakdownSpain: 444 citing papers, 2.6% of this breakdownAustralia: 442 citing papers, 2.6% of this breakdownSweden: 393 citing papers, 2.3% of this breakdownJapan: 386 citing papers, 2.3% of this breakdown
0%29.8%Other 24.9%

Institutions

Fields

  • Medicine76.4%
  • Biochemistry, Genetics and Molecular Biology13.6%
  • Nursing3.4%
  • Immunology and Microbiology1.5%
  • Computer Science1.1%
  • Chemistry0.6%
  • Other3.4%

Topics

  • Prostate Cancer Treatment and Research11.9%
  • Prostate Cancer Diagnosis and Treatment10.1%
  • Bladder and Urothelial Cancer Treatments4.9%
  • Urinary and Genital Oncology Studies2.7%
  • Urinary Bladder and Prostate Research2.2%
  • Cancer, Lipids, and Metabolism1.9%
  • Other66.3%

Coauthors

All papers

Open in search
  1. Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer

    Authors: Matthew R. Smith, Maha Hussain, Fred Saad, Karim Fizazi, Cora N. Sternberg, E. David Crawford, Evgeny Kopyltsov, Chandler H. Park, Boris Alekseev, Álvaro Montesa-Pino, Dingwei Ye, Francis Parnis, Felipe Cruz, Teuvo L.J. Tammela, Hiroyoshi Suzuki, Tapio Utriainen, Cheng Fu, Motohide Uemura, María J. Méndez-Vidal, Benjamin L. Maughan, Heikki Joensuu, Silke Thiele, Rui Li, Iris Kuss, Bertrand Tombal - New England Journal of Medicine 2022 cited by 904

  2. Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer

    Authors: H. Barton Grossman, Ronald B. Natale, Catherine M. Tangen, V. O. Speights, Nicholas J. Vogelzang, Donald L. Trump, Ralph W. deVere White, Michael F. Sarosdy, David P. Wood, Derek Raghavan, E. David Crawford - New England Journal of Medicine 2003 cited by 2,644

  3. Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

    Authors: Daniel P. Petrylak, Catherine M. Tangen, Maha Hussain, Primo N. Lara, Jeffrey A. Jones, Mary Ellen Taplin, Patrick A. Burch, Donna L. Berry, Carol M. Moinpour, Manish Kohli, Mitchell C. Benson, Eric J. Small, Derek Raghavan, E. David Crawford - New England Journal of Medicine 2004 cited by 3,687

  4. Characterising the castration-resistant prostate cancer population: a systematic review

    Authors: Michael Kirby, Caroline S. Hirst, E. David Crawford - International Journal of Clinical Practice 2011 cited by 862

  5. Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers

    Authors: Scott M. Lippman, Eric A. Klein, Phyllis J. Goodman, M. Scott Lucia, Ian M. Thompson, Leslie G. Ford, Howard L. Parnes, Lori M. Minasian, J. Michael Gaziano, Jo Ann Hartline, J. Kellogg Parsons, James D. Bearden, E. David Crawford, Gary E. Goodman, Jaime O. Claudio, Eric Winquist, Elise D. Cook, Daniel D. Karp, Philip Walther, Michael M. Lieber, Alan R. Kristal, Amy K. Darke, Kathryn B. Arnold, Peter Ganz, Regina M. Santella, Demetrius Albanes, Philip R. Taylor, Jeffrey L. Probstfield, T. J. Jagpal, John J. Crowley, Frank L. Meyskens, Laurence H. Baker, Charles A. Coltman - JAMA 2008 cited by 2,115

  6. Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial

    Authors: Maha Hussain, Bertrand Tombal, Fred Saad, Karim Fizazi, Cora N. Sternberg, E. David Crawford, Neal D. Shore, Evgeny Kopyltsov, Arash Rezazadeh Kalebasty, Martin Bögemann, Dingwei Ye, Felipe José Silva Melo Cruz, Hiroyoshi Suzuki, Shivani Kapur, Shankar Srinivasan, Frank Verholen, Iris Kuss, Heikki Joensuu, Matthew R. Smith - Journal of Clinical Oncology 2023 cited by 215

  7. Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter

    Authors: Ian M. Thompson, Donna K. Pauler, Phyllis J. Goodman, Catherine M. Tangen, M. Scott Lucia, Howard L. Parnes, Lori M. Minasian, Leslie G. Ford, Scott M. Lippman, E. David Crawford, John J. Crowley, Charles A. Coltman - New England Journal of Medicine 2004 cited by 2,433

  8. MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY

    Authors: Donald L. Lamm, Brent A. Blumenstein, John D. Crissman, James E. Montie, James E. Gottesman, Bruce A. Lowe, Michael F. Sarosdy, ROBERT D. BOHL, H. Barton Grossman, Thomas Beck, Joseph T. Leimert, E. David Crawford - The Journal of Urology 2000 cited by 1,316

  9. Colorectal-Cancer Incidence and Mortality with Screening Flexible Sigmoidoscopy

    Authors: Robert E. Schoen, Paul F. Pinsky, Joel L. Weissfeld, Lance Yokochi, Timothy R. Church, Adeyinka O. Laiyemo, Robert S. Bresalier, Gerald L. Andriole, Saundra S. Buys, E. David Crawford, Mona N. Fouad, Claudine Isaacs, Christine Cole Johnson, Douglas J. Reding, Barbara O’Brien, Danielle M. Carrick, Patrick Wright, Thomas L. Riley, Mark P. Purdue, Grant Izmirlian, Barnett S. Kramer, Anthony B. Miller, John K. Gohagan, Philip C. Prorok, Christine D. Berg - New England Journal of Medicine 2012 cited by 1,025

  10. Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial

    Authors: Philip C. Prorok, Gerald L. Andriole, Robert S. Bresalier, Saundra S. Buys, David Chia, E. David Crawford, Ronald Fogel, Edward P. Gelmann, Fred Gilbert, Marsha Hasson, Richard B. Hayes, Christine Cole Johnson, Jack S. Mandel, Albert Oberman, Barbara O’Brien, Martin M. Oken, Sameer Rafla, Douglas J. Reding, Wilmer M. Rutt, Joel L. Weissfeld, Lance Yokochi, John K. Gohagan - Controlled Clinical Trials 2000 cited by 1,041

  11. Intermittent versus Continuous Androgen Deprivation in Prostate Cancer

    Authors: Maha Hussain, Catherine M. Tangen, Donna L. Berry, Celestia S. Higano, E. David Crawford, Glenn Liu, George Wilding, Stephen M. Prescott, S.K. Sundaram, Eric J. Small, Nancy A. Dawson, Bryan Donnelly, Peter Venner, Ulka N. Vaishampayan, Paul F. Schellhammer, David I. Quinn, Derek Raghavan, Benjamin Ely, Carol M. Moinpour, Nicholas J. Vogelzang, Ian M. Thompson - New England Journal of Medicine 2013 cited by 568

  12. Mortality Results from a Randomized Prostate-Cancer Screening Trial

    Authors: Gerald L. Andriole, E. David Crawford, Robert L. Grubb, Saundra S. Buys, David Chia, Timothy R. Church, Mona N. Fouad, Edward P. Gelmann, Paul A. Kvale, Douglas J. Reding, Joel L. Weissfeld, Lance Yokochi, Barbara O’Brien, Jonathan D. Clapp, Joshua M. Rathmell, Thomas L. Riley, Richard B. Hayes, Barnett S. Kramer, Grant Izmirlian, Anthony B. Miller, Paul F. Pinsky, Philip C. Prorok, John K. Gohagan, Christine D. Berg - New England Journal of Medicine 2009 cited by 2,917

  13. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019

    Authors: Veda N. Giri, Karen E. Knudsen, William Kevin Kelly, Heather H. Cheng, Kathleen A. Cooney, Michael S. Cookson, William L. Dahut, Scott M. Weissman, Howard R. Soule, Daniel P. Petrylak, Adam P. Dicker, Saud H. AlDubayan, Amanda E. Toland, Colin C. Pritchard, Curtis A. Pettaway, Mary B. Daly, James L. Mohler, J. Kellogg Parsons, Peter R. Carroll, Robert Pilarski, Amie Blanco, Ashley Woodson, Alanna Kulchak Rahm, Mary-Ellen Taplin, Thomas J. Polascik, Brian T. Helfand, Colette Hyatt, Alicia K. Morgans, Felix Y. Feng, Michael P. Mullane, Jacqueline Powers, Raoul S. Concepcion, Daniel W. Lin, Richard C. Wender, James Ryan Mark, Anthony J. Costello, Arthur L. Burnett, Oliver Sartor, William B. Isaacs, Jianfeng Xu, Jeffrey N. Weitzel, Gerald L. Andriole, Himisha Beltran, Alberto Briganti, Lindsey Byrne, Anne Calvaresi, Thenappan Chandrasekar, David Y.T. Chen, Robert B. Den, Albert Dobi, E. David Crawford, James A. Eastham, Scott E. Eggener, Matthew L. Freedman, Marc B. Garnick, Patrick T. Gomella, Nathan Handley, Mark Hurwitz, Joseph K. Izes, R. Jeffrey Karnes, Costas D. Lallas, Lucia R. Languino, Stacy Loeb, Ana María López, Kevin R. Loughlin, Grace Lu‐Yao, S. Bruce Malkowicz, Mark Mann, Patrick Mille, Martin Miner, Todd M. Morgan, José Moreno, Lorelei A. Mucci, Ronald E. Myers, Sarah M. Nielsen, Brock O’Neil, Wayne H. Pinover, Peter A. Pinto, Wendy Poage, Ganesh V. Raj, Timothy R. Rebbeck, Charles J. Ryan, Howard M. Sandler, Matthew J. Schiewer, Emily Scott, Brittany M. Szymaniak, William Tester, Edouard J. Trabulsi, Neha Vapiwala, Evan Y. Yu, Charnita Zeigler‐Johnson, Leonard G. Gomella - Journal of Clinical Oncology 2020 cited by 279

  14. Absolute Prostate-Specific Antigen Value After Androgen Deprivation Is a Strong Independent Predictor of Survival in New Metastatic Prostate Cancer: Data From Southwest Oncology Group Trial 9346 (INT-0162)

    Authors: Maha Hussain, Catherine M. Tangen, Celestia S. Higano, Paul F. Schelhammer, James R. Faulkner, E. David Crawford, George Wilding, A. Akdaş, Eric J. Small, Bryan Donnelly, Gary R. MacVicar, Derek Raghavan - Journal of Clinical Oncology 2006 cited by 507

  15. A study of high‐dose oral silybin‐phytosome followed by prostatectomy in patients with localized prostate cancer

    Authors: Thomas W. Flaig, Michael Glodé, Daniel L. Gustafson, Adrie van Bokhoven, Yuzhen Tao, Shandra Wilson, Lih‐Jen Su, Yuan Li, Gail S. Harrison, Rajesh Agarwal, E. David Crawford, M. Scott Lucia, Michaël Pollak - The Prostate 2010 cited by 191

  16. Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer

    Authors: Robert C. Flanigan, Sydney E. Salmon, Brent A. Blumenstein, Scott I. Bearman, Vivek Roy, Patrick C. McGrath, J. R. Caton, Nikhil C. Munshi, E. David Crawford - New England Journal of Medicine 2001 cited by 1,735

  17. Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up

    Authors: G. L. Andriole, E. David Crawford, Robert L. Grubb, Saundra S. Buys, David Chia, Timothy R. Church, Mona N. Fouad, Claudine Isaacs, Paul A. Kvale, Douglas J. Reding, Joel L. Weissfeld, Lance Yokochi, Barbara O’Brien, Lawrence R. Ragard, Jonathan D. Clapp, Joshua Rathmell, T. Riley, Ann W. Hsing, Grant Izmirlian, Paul F. Pinsky, B S Kramer, Andrea Miller, John K. Gohagan, Philip C. Prorok, for the PLCO Project Team - JNCI Journal of the National Cancer Institute 2012 cited by 1,121

  18. Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men

    Authors: Rianne J. Hendriks, Marloes M. G. van der Leest, Bas Israël, Gerjon Hannink, Anglita Yantisetiasti, Erik B. Cornel, Christina A. Hulsbergen‐van de Kaa, O.S. Klaver, J.P. Michiel Sedelaar, Wim Van Criekinge, Hans de Jong, Peter F.A. Mulders, E. David Crawford, Jeroen Veltman, Jack A. Schalken, Jelle O. Barentsz, Inge M. van Oort - Prostate Cancer and Prostatic Diseases 2021 cited by 82

  19. The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia

    Authors: John D. McConnell, Claus G. Roehrborn, Oliver Bautista, Gerald L. Andriole, Christopher Dixon, John W. Kusek, Herbert Lepor, Kevin T. McVary, Leroy M. Nyberg, Harry S. Clarke, E. David Crawford, Ananias C. Diokno, John P. Foley, Harris E. Foster, Stephen C. Jacobs, Steven A. Kaplan, Karl J. Kreder, Michael M. Lieber, M. Scott Lucia, Gary J. Miller, Mani Menon, Douglas F. Milam, Joe Ramsdell, Noah S. Schenkman, Kevin M. Slawin, Joseph A. Smith - New England Journal of Medicine 2003 cited by 2,040

  20. Screening by Chest Radiograph and Lung Cancer Mortality

    Authors: Martin M. Oken, Willam G. Hocking, Paul A. Kvale, Gerald L. Andriole, Saundra S. Buys, Timothy R. Church, E. David Crawford, Mona N. Fouad, Claudine Isaacs, Douglas J. Reding, Joel L. Weissfeld, Lance Yokochi, Barbara O’Brien, Lawrence R. Ragard, Joshua M. Rathmell, Thomas L. Riley, Patrick Wright, Neil Caparaso, Ping Hu, Grant Izmirlian, Paul F. Pinsky, Philip C. Prorok, Barnett S. Kramer, Anthony B. Miller, John K. Gohagan, Christine D. Berg, for the PLCO Project Team - JAMA 2011 cited by 654

  21. Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials

    Authors: Alex Tsodikov, Roman Gulati, Eveline A.M. Heijnsdijk, Paul F. Pinsky, Sue Moss, Sheng Qiu, Tiago M. de Carvalho, Jonas Hugosson, Christine D. Berg, Anssi Auvinen, Gerald L. Andriole, Monique J. Roobol, E. David Crawford, Vera Nelen, Maciej Kwiatkowski, Marco Zappa, M. Luján, Arnauld Villers, Eric J. Feuer, Harry J. de Koning, Angela B. Mariotto, Ruth Etzioni - Annals of Internal Medicine 2017 cited by 247

  22. Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations

    Authors: E. David Crawford, Axel Heidenreich, Nathan Lawrentschuk, Bertrand Tombal, Antônio Carlos Lima Pompeo, Arturo Mendoza-Valdés, Kurt Miller, F.M.J. Debruyne, Laurence Klotz - Prostate Cancer and Prostatic Diseases 2018 cited by 377

  23. Extended mortality results for prostate cancer screening in the PLCO trial with median follow‐up of 15 years

    Authors: Paul F. Pinsky, Philip C. Prorok, Kelly J. Yu, Barnett S. Kramer, Amanda Black, John K. Gohagan, E. David Crawford, Robert L. Grubb, Gerald L. Andriole - Cancer 2016 cited by 251

  24. Cytoreductive Nephrectomy in Patients With Metastatic Renal Cancer: A Combined Analysis

    Authors: Robert C. Flanigan, G. Mickisch, Richard Sylvester, Cathy Tangen, Hendrik Van Poppel, E. David Crawford - The Journal of Urology 2004 cited by 874